Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease

Details for Australian Patent Application No. 2010201459 (hide)

Owner Seattle Genetics, Inc.

Inventors Toki, Brian E.; Senter, Peter D.; Doronina, Svetlana

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010201459

Parent 2003263964

Filing date 13 April 2010

Wipo publication date 6 May 2010

International Classifications

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

29 April 2010 Complete Application Filed

6 May 2010 Application Open to Public Inspection

  Published as AU-A-2010201459

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010201460-Methods and devices for identifying sealing port size

2010201458-Use of mGluR5 (esp. AFQ056) in GI (esp. GERD)